P&T
Our
Other
Journal
MediMedia Managed Markets
Managed Care

 

Costly biologics have plan sponsors looking at benefit designs

Costly biologics have plan sponsors looking at benefit designs

F. Randy Vogenberg, PhD, RPh: Given the high costs of specialty drugs, sponsors of health plans (especially self-funded ones) are gathering information on costs, benefits, and outcomes to determine what kinds of coverage to offer.